- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04511663
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients
The Effectiveness of a 2-year Assertive Community Treatment on Schizophrenic Patients in an Urban District of Shanghai
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Assertive community treatment (ACT) is a community-based, patient-centered, and rehabilitation-oriented model based on multidisciplinary service teams. It has been proved to be suitable for the management of patients with severe mental disorder in the community. In this study, we aimed to investigate the effectiveness of ACT in an urban district of Shanghai with a larger sample size and a 24-month duration of follow up. We hypothesized that patients assigned into ACT would show better improvement in psychiatric symptoms and social function.The study protocol was approved by the Institutional Review Board in Shanghai Mental Health Center.
Aim of the study: 1.1 To explore the effectiveness of assertive community treatment in patients with schizophrenia. 1.2 The patients were followed up for 24 months to explore the duration of ACT.
Introduction of the study: Patients who previously diagnosed as schizophrenia according to International Classification of Diseases 10th Revision (ICD-10) in the psychiatric hospitals would receive basic public health service in the community. The selected schizophrenic patients were randomly assigned into intervention group and control group by a computer randomization algorithm. During the following 2 years, the control group received basic public health services in the community while the intervention group received ACT. Clinical assessments were conducted at baseline and every 6 months till the end of the 2-year study. A single-blind method was used, in which all the assessments were independently completed by trained psychiatrists who didn't know the grouping.The Positive and Negative Symptoms Scale (PANSS) and the Personal and Social Performance Scale (PSP) were measured at baseline and every 6 months during the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shanghai, China
- Shanghai Mental Health Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged between 18 and 50 years old;
- course of disease between 2 and 20 years;
- living with family members who can function as their caregivers;
- disease condition was stable and the total score of the Positive and Negative Symptoms Scale (PANSS) is less than 60.
Exclusion Criteria:
- women during pregnancy;
- having mental retardation or psychoactive substance-induced mental disorders;
- having serious physical condition.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: intervention group
The intervention group received assertive community treatment, in which the team consisted of psychiatrists, nurses, clinical psychologists, social workers, rehabilitation teachers.
|
The intervention team consisted of psychiatrists, nurses, clinical psychologists, social workers, rehabilitation teachers.
The specific services provided by the team include individual service plan.
Each patient got a comprehensive evaluation within one month to establish treatment goals and individual intervention plan, rehabilitation training, family intervention peer support group, individual psychological counseling and crisis intervention.
|
|
Other: control group
The control group received basic public health services which is regular medical follow-up including symptom and medication evaluation, social function evaluation and physical examination after hospital discharge.
|
The control group received regular medical follow-up including symptom and medication evaluation, social function evaluation and physical examination after hospital discharge.
The frequency was once a quarter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PANSS
Time Frame: 6 months
|
PANSS(Positive and Negative Syndrome Scale) is a relatively mature assessment tool commonly used in clinical research to assess the severity of schizophrenia symptoms.
It consists of a positive symptom subscale (7 items), a negative symptom subscale (7 items) and a general psychopathological symptom subscale (16 items), a total of 30 items.Each item has specific definitions and operational grading criteria.
It is divided into 7 grades according to the level of psychopathology (1~7 points).
The higher the score, the heavier the symptoms.
The total score of PANSS is 30- 210 points, the positive symptom subscale and the negative symptom subscale are 7-49 points, and the general psychopathological symptoms subscale is 16 to 112 points.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PSP
Time Frame: 6 months
|
PSP (The Personal and Social Performance Scale) uses a 100-point rating scale to assesses social functioning.
A score of 71-100 indicates mild difficulties in social functioning; 31-70 indicates varying degrees of impairment and disability; and 0-30 indicates poor functioning that requires intensive support or supervision.
Chinese version of the PSP demonstrated good psychometric characteristics
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jun Cai, Shanghai Mental Health Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WeiboZhang
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Elazığ Mental Health and Diseases HospitalCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedSchizophrenia DisorderTurkey (Türkiye)
Clinical Trials on Assertive community treatment
-
Universitätsklinikum Hamburg-EppendorfCompletedSchizophreniaGermany
-
University Hospital, GenevaCompletedSubstance Use DisordersSwitzerland
-
Bispebjerg HospitalCopenhagen Hospital CorporationUnknown
-
University of RochesterNational Institute of Mental Health (NIMH)CompletedPsychotic DisordersUnited States
-
University of WashingtonCompletedSchizophrenia | Bipolar Disorder | Severe Mental Illness
-
MaineHealthColumbia University; University of California, Irvine; Harvard UniversityCompletedPsychotic Disorders | Prodromal Schizophrenia | Severe Major Depression With Psychotic Features | Severe Bipolar Disorder With Psychotic FeaturesUnited States
-
Veterans Medical Research FoundationNational Institute of Mental Health (NIMH)Completed
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
Amager HospitalActive, not recruitingBipolar Disorder | Psychosis | Personality Disorder, Borderline | Severe Depression | Schizophreniform Disorders | PtsdDenmark
-
Yale UniversityCompletedSchizophrenia and Disorders With Psychotic FeaturesUnited States